ENZO BIOCHEM INC Quarterly Operating Income (Loss) in USD from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Enzo Biochem Inc quarterly/annual Operating Income (Loss) history and growth rate from Q3 2010 to Q3 2024.
  • Enzo Biochem Inc Operating Income (Loss) for the quarter ending October 31, 2024 was -$3.62M, a 33.9% increase year-over-year.
  • Enzo Biochem Inc Operating Income (Loss) for the twelve months ending October 31, 2024 was -$10.5M, a 58.9% increase year-over-year.
  • Enzo Biochem Inc annual Operating Income (Loss) for 2024 was -$12.4M, a 50% increase from 2023.
  • Enzo Biochem Inc annual Operating Income (Loss) for 2023 was -$24.7M, a 45.3% decline from 2022.
  • Enzo Biochem Inc annual Operating Income (Loss) for 2022 was -$17M, a 2561% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$10.5M -$3.62M +$1.85M +33.9% Aug 1, 2024 Oct 31, 2024 10-Q 2024-12-16
Q2 2024 -$12.4M -$2.66M +$4.55M +63.1% May 1, 2024 Jul 31, 2024 10-K 2024-10-29
Q1 2024 -$16.9M -$2.04M +$6.31M +75.5% Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-13
Q4 2023 -$23.2M -$2.19M +$2.36M +51.9% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-13
Q3 2023 -$25.6M -$5.48M -$847K -18.3% Aug 1, 2023 Oct 31, 2023 10-Q 2024-12-16
Q2 2023 -$24.7M -$7.21M +$2.93M +28.9% May 1, 2023 Jul 31, 2023 10-K 2024-10-29
Q1 2023 -$27.7M -$8.35M -$5.22M -166% Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-13
Q4 2022 -$22.4M -$4.55M -$2.62M -136% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-13
Q3 2022 -$19.8M -$4.63M -$2.8M -153% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-15
Q2 2022 -$17M -$10.1M -$6.55M -183% May 1, 2022 Jul 31, 2022 10-K 2023-11-03
Q1 2022 -$10.5M -$3.14M -$5.2M -252% Feb 1, 2022 Apr 30, 2022 10-Q 2023-06-14
Q4 2021 -$5.27M -$1.92M -$3.63M -212% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-20
Q3 2021 -$1.64M -$1.83M -$2.33M -469% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-12
Q2 2021 $692K -$3.58M +$849K +19.2% May 1, 2021 Jul 31, 2021 10-K 2022-10-14
Q1 2021 -$157K $2.07M +$11.8M Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-09
Q4 2020 -$11.9M $1.71M +$9.72M Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-14
Q3 2020 -$21.7M $497K +$8.7M Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-15
Q2 2020 -$30.4M -$4.43M +$1.23M +21.8% May 1, 2020 Jul 31, 2020 10-K 2022-10-14
Q1 2020 -$31.6M -$9.72M -$32M -144% Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-11
Q4 2019 $392K -$8.01M +$884K +9.94% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-16
Q3 2019 -$492K -$8.2M -$2.23M -37.2% Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-11
Q2 2019 $1.73M -$5.67M +$47K +0.82% May 1, 2019 Jul 31, 2019 10-K 2021-10-12
Q1 2019 $1.69M $22.3M +$25.1M Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-09
Q4 2018 -$23.4M -$8.89M -$5.88M -195% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-06
Q3 2018 -$17.5M -$5.98M -$5.34M -837% Aug 1, 2018 Oct 31, 2018 10-Q 2019-12-10
Q2 2018 -$12.2M -$5.71M -$5.16M -940% May 1, 2018 Jul 31, 2018 10-K 2020-10-19
Q1 2018 -$7M -$2.8M -$2.54M -980% Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-10
Q4 2017 -$4.46M -$3.02M -$1.95M -184% Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-11
Q3 2017 -$2.51M -$638K +$640K +50.1% Aug 1, 2017 Oct 31, 2017 10-Q 2018-12-10
Q2 2017 -$3.15M -$549K -$37.8M -101% May 1, 2017 Jul 31, 2017 10-K 2019-10-15
Q1 2017 $34.7M -$259K +$2.26M +89.7% Feb 1, 2017 Apr 30, 2017 10-Q 2018-06-11
Q4 2016 $32.4M -$1.06M -$8.52M -114% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-12
Q3 2016 $40.9M -$1.28M -$5.92M -128% Aug 1, 2016 Oct 31, 2016 10-Q 2017-12-07
Q2 2016 $46.8M $37.3M +$28.7M +333% May 1, 2016 Jul 31, 2016 10-K 2018-10-15
Q1 2016 $18.2M -$2.51M +$332K +11.7% Feb 1, 2016 Apr 30, 2016 10-Q 2017-06-08
Q4 2015 $17.9M $7.46M +$11.3M Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-13
Q3 2015 $6.52M $4.64M +$7.72M Aug 1, 2015 Oct 31, 2015 10-Q 2016-12-08
Q2 2015 -$1.21M $8.61M +$11.7M May 1, 2015 Jul 31, 2015 10-K 2017-09-27
Q1 2015 -$12.9M -$2.85M -$2.29M -413% Feb 1, 2015 Apr 30, 2015 10-Q 2016-06-08
Q4 2014 -$10.6M -$3.88M -$328K -9.23% Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-09
Q3 2014 -$10.2M -$3.08M -$64K -2.12% Aug 1, 2014 Oct 31, 2014 10-Q 2015-12-08
Q2 2014 -$10.2M -$3.05M +$341K +10.1% May 1, 2014 Jul 31, 2014 10-K 2016-10-13
Q1 2014 -$10.5M -$555K +$5.05M +90.1% Feb 1, 2014 Apr 30, 2014 10-Q 2015-06-09
Q4 2013 -$15.6M -$3.55M +$2.44M +40.7% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-12
Q3 2013 -$18M -$3.02M +$964K +24.2% Aug 1, 2013 Oct 31, 2013 10-Q 2014-12-09
Q2 2013 -$19M -$3.39M +$25.4M +88.2% May 1, 2013 Jul 31, 2013 10-K 2015-10-13
Q1 2013 -$44.4M -$5.61M -$2.09M -59.3% Feb 1, 2013 Apr 30, 2013 10-Q 2014-06-09
Q4 2012 -$42.3M -$5.99M -$2.19M -57.6% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-11
Q3 2012 -$40.1M -$3.98M +$378K +8.67% Aug 1, 2012 Oct 31, 2012 10-Q 2013-12-10
Q2 2012 -$40.5M -$28.8M -$24.8M -618% May 1, 2012 Jul 31, 2012 10-K 2014-10-09
Q1 2012 -$15.7M -$3.52M -$1.26M -55.4% Feb 1, 2012 Apr 30, 2012 10-Q 2013-06-10
Q4 2011 -$14.4M -$3.8M +$1.76M +31.7% Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-12
Q3 2011 -$16.2M -$4.36M -$3.28M -301% Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-10
Q2 2011 -$12.9M -$4.01M May 1, 2011 Jul 31, 2011 10-K 2013-10-15
Q1 2011 -$2.27M Feb 1, 2011 Apr 30, 2011 10-Q 2012-06-11
Q4 2010 -$5.56M Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-12
Q3 2010 -$1.09M Aug 1, 2010 Oct 31, 2010 10-Q 2011-12-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.